Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Sell
50
SSMXY Quote, Financials, Valuation and Earnings
Last price:
$18.63
Seasonality move
:
3.21%
Day range:
$18.34 - $18.70
52-week range:
$14.38 - $22.00
Dividend yield:
1.01%
P/E ratio:
33.33x
P/S ratio:
3.63x
P/B ratio:
3.76x
Volume:
57.5K
Avg. volume:
86.8K
1-year change:
2.21%
Market cap:
$11.6B
Revenue:
$3.2B
EPS (TTM):
$0.56
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Sysmex has -- downside to fair value with a price target of -- per share.
SSMXY vs. S&P 500
-
Over the past 5 trading days, Sysmex has underperformed the S&P 500 by -1.05% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Sysmex does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Sysmex has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Sysmex reported revenues of $718.1M.
Earnings Growth
-
Sysmex has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Sysmex reported earnings per share of $0.11.
Enterprise value:
11.2B
EV / Invested capital:
--
Price / LTM sales:
3.63x
EV / EBIT:
20.55x
EV / Revenue:
3.49x
PEG ratio (5yr expected):
8.40x
EV / Free cash flow:
117.76x
Price / Operating cash flow:
109.89x
Enterprise value / EBITDA:
14.08x
Gross Profit (TTM):
$1.7B
Return On Assets:
9.01%
Net Income Margin (TTM):
10.9%
Return On Equity:
12%
Return On Invested Capital:
11.96%
Operating Margin:
14.96%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $3.2B | $3.1B | $3.2B | $694.9M | $718.1M | |
| Gross Profit | $1.6B | $1.6B | $1.7B | $367.4M | $385.1M | |
| Operating Income | $550.1M | $571.4M | $565.5M | $96.8M | $107.4M | |
| EBITDA | $792.3M | $752.9M | $794.6M | $159.8M | $175.5M | |
| Diluted EPS | $0.58 | $0.54 | $0.56 | $0.10 | $0.11 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.9B | $2.2B | $2B | $2.1B | $2.4B | |
| Total Assets | $3.6B | $4B | $3.5B | $3.7B | $4.3B | |
| Current Liabilities | $648.6M | $796.5M | $675.1M | $693.4M | $752M | |
| Total Liabilities | $897.4M | $1.1B | $905.7M | $921.8M | $1.2B | |
| Total Equity | $2.7B | $2.9B | $2.6B | $2.8B | $3.1B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2023-03-31 | 2024-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $523.2M | $509.8M | $442.9M | $226.9M | $179.6M | |
| Cash From Investing | -$312.2M | -$383.2M | -$380.9M | -$110.1M | -$97.4M | |
| Cash From Financing | -$183M | -$179.5M | -$62.5M | -$21M | $10.1M | |
| Free Cash Flow | $237.9M | $195M | $95M | $120.3M | $80.9M | |
SSMXY
Sector
Market Cap
$11.6B
$45.2M
Price % of 52-Week High
84.68%
46.55%
Dividend Yield
1.01%
0%
Shareholder Yield
1.92%
-0.75%
1-Year Price Total Return
2.21%
-33.5%
Beta (5-Year)
0.888
0.747
Dividend yield:
1.01%
Annualized payout:
$0.18
Payout ratio:
16.51%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$18.43
200-day SMA
Buy
Level
$17.96
Bollinger Bands (100)
Sell
Level
18.53 - 20.17
Chaikin Money Flow
Buy
Level
6.7M
20-day SMA
Buy
Level
$18.44
Relative Strength Index (RSI14)
Sell
Level
46.70
ADX Line
Sell
Level
25.61
Williams %R
Neutral
Level
-25.2475
50-day SMA
Sell
Level
$19.48
MACD (12, 26)
Sell
Level
-0.24
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
6.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.7311)
Buy
CA Score
(Annual)
Level (1.4232)
Buy
Beneish M-Score
(Annual)
Level (-2.5568)
Buy
Momentum Score
Level (6)
Buy
Ohlson Score
Level (-2.9499)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.
Stock Forecast FAQ
In the current month, SSMXY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SSMXY average analyst price target in the past 3 months is --.
-
Where Will Sysmex Stock Be In 1 Year?
According to analysts, the consensus estimate is that Sysmex share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Sysmex?
Analysts are divided on their view about Sysmex share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sysmex is a Sell and believe this share price will rise from its current level to --.
-
What Is Sysmex's Price Target?
The price target for Sysmex over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SSMXY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Sysmex is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of SSMXY?
You can purchase shares of Sysmex via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sysmex shares.
-
What Is The Sysmex Share Price Today?
Sysmex was last trading at $18.63 per share. This represents the most recent stock quote for Sysmex. Yesterday, Sysmex closed at $18.63 per share.
-
How To Buy Sysmex Stock Online?
In order to purchase Sysmex stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
